{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:33:27Z","timestamp":1761708807984},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T00:00:00Z","timestamp":1348012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1476-511x-11-120","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T02:14:31Z","timestamp":1348020871000},"source":"Crossref","is-referenced-by-count":25,"title":["Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum\/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity"],"prefix":"10.1186","volume":"11","author":[{"given":"Si-Yuan","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kam-Ming","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,19]]},"reference":[{"key":"781_CR1","doi-asserted-by":"publisher","first-page":"794","DOI":"10.5812\/kowsar.1735143X.1104","volume":"11","author":"R Kelishadi","year":"2011","unstructured":"Kelishadi R, Poursafa P: Obesity and air pollution: Global risk factors for pediatric non-alcoholic fatty liver disease. Hepat Mon. 2011, 11: 794-802.","journal-title":"Hepat Mon"},{"key":"781_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1751-2980.2011.00487.x","volume":"12","author":"SH Chen","year":"2011","unstructured":"Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM: Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011, 12: 125-130. 10.1111\/j.1751-2980.2011.00487.x","journal-title":"J Dig Dis"},{"key":"781_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1499-3872(11)60120-3","volume":"11","author":"XY Duan","year":"2012","unstructured":"Duan XY, Qiao L, Fan JG: Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2012, 11: 18-27. 10.1016\/S1499-3872(11)60120-3","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"781_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0253-7613.48878","volume":"41","author":"S Jain","year":"2009","unstructured":"Jain S, Vaishnavi V, Chakraborty BS: The effect of dyslipidemic drugs on mortality: a meta-analysis. Indian J Pharmacol. 2009, 41: 4-8. 10.4103\/0253-7613.48878","journal-title":"Indian J Pharmacol"},{"issue":"Suppl","key":"781_CR5","first-page":"S57","volume":"54","author":"MH Kim","year":"2011","unstructured":"Kim MH, Kang KS: Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling. Prev Med. 2011, 54 (Suppl): S57-S63.","journal-title":"Prev Med"},{"key":"781_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1478-3231.2011.02730.x","volume":"32","author":"JA Parnell","year":"2011","unstructured":"Parnell JA, Raman M, Rioux KP, Reimer RA: The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int. 2011, 32: 701-711.","journal-title":"Liver Int"},{"key":"781_CR7","first-page":"33","volume":"44","author":"F Salamone","year":"2011","unstructured":"Salamone F, Galvano F, Marino A, Paternostro C, Tibullo D, Bucchieri F, Mangiameli A, Parola M, Bugianesi E, Li Volti G: Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. Dig Liver Dis. 2011, 44: 33-42.","journal-title":"Dig Liver Dis"},{"key":"781_CR8","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/hep.24544","volume":"54","author":"CO Zein","year":"2011","unstructured":"Zein CO, Yerian LM, Gogate P, Lopez R, Kirwan JP, Feldstein AE, McCullough AJ: Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology. 2011, 54: 1610-1619. 10.1002\/hep.24544","journal-title":"Hepatology"},{"key":"781_CR9","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.metabol.2009.12.017","volume":"59","author":"JM Wong","year":"2010","unstructured":"Wong JM, Kendall CW, de Souza R, Emam A, Marchie A, Vidgen E, Holmes C, Jenkins DJ: The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial. Metabolism. 2010, 59: 1331-1340. 10.1016\/j.metabol.2009.12.017","journal-title":"Metabolism"},{"key":"781_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jep.2008.04.020","volume":"118","author":"A Panossian","year":"2008","unstructured":"Panossian A, Wikman G: Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol. 2008, 118: 183-212. 10.1016\/j.jep.2008.04.020","journal-title":"J Ethnopharmacol"},{"key":"781_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/biof.179","volume":"37","author":"PY Lam","year":"2011","unstructured":"Lam PY, Leong PK, Chen N, Ko KM: Schisandrin B enhances the glutathione redox cycling and protects against oxidant injury in different types of cultured cells. Biofactors. 2011, 37: 439-446. 10.1002\/biof.179","journal-title":"Biofactors"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1742-7843.2008.00343.x","volume":"104","author":"YN Yu","year":"2009","unstructured":"Yu YN, Chen H, Li Y: Effect of bicyclol on cisplatin-induced hepatotoxicity in the hepatocarcinoma 22 tumour-bearing mice. Basic Clin Pharmacol Toxicol. 2009, 104: 300-305. 10.1111\/j.1742-7843.2008.00343.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"781_CR13","first-page":"538","volume":"82","author":"S Cui","year":"2002","unstructured":"Cui S, Wang M, Fan G: Anti-HBV efficacy of bifendate in treatment of chronic hepatitis B, a primary study. Nat Med J Chin. 2002, 82: 538-540. Chinese.","journal-title":"Nat Med J Chin"},{"key":"781_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejphar.2006.09.011","volume":"552","author":"SY Pan","year":"2006","unstructured":"Pan SY, Yang R, Dong H, Yu ZL, Ko KM: Bifendate treatment attenuates hepatic steatosis in cholesterol\/bile salt- and high-fat diet-induced hypercholesterolemia in mice. Eur J Pharmacol. 2006, 552: 170-177. 10.1016\/j.ejphar.2006.09.011","journal-title":"Eur J Pharmacol"},{"key":"781_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1211\/jpp.60.3.0017","volume":"60","author":"SY Pan","year":"2008","unstructured":"Pan SY, Dong H, Zhao XY, Xiang CJ, Fang HY, Fong WF, Ko KM: Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice. J Pharm Pharmacol. 2008, 60: 399-340.","journal-title":"J Pharm Pharmacol"},{"key":"781_CR16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1211\/jpp.59.12.0007","volume":"59","author":"SY Pan","year":"2007","unstructured":"Pan SY, Dong H, Yu ZL, Zhao XY, Xiang CJ, Wang H, Fong WF, Ko KM: Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice. J Pharm Pharmacol. 2007, 59: 1657-1662.","journal-title":"J Pharm Pharmacol"},{"key":"781_CR17","volume-title":"Evid Based Complement Alternat Med","author":"SY Pan","year":"2011","unstructured":"Pan SY, Yu ZL, Dong H, Xiang CJ, Fong WF, Ko KM: Ethanol extract of Fructus Schisandrae decreases hepatic triglyceride level in mice fed with a high fat\/cholesterol diet, with attention to acute toxicity. Evid Based Complement Alternat Med. 2011, 10.1093\/ecam\/nep070729412. 2011.729412."},{"key":"781_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11886-011-0219-9","volume":"13","author":"B Sjouke","year":"2011","unstructured":"Sjouke B, Kusters DM, Kastelein JJ, Hovingh GK: Familial hypercholesterolemia: present and future management. Curr Cardiol Rep. 2011, 13: 527-536. 10.1007\/s11886-011-0219-9","journal-title":"Curr Cardiol Rep"},{"key":"781_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11886-011-0220-3","volume":"13","author":"BG Talayero","year":"2011","unstructured":"Talayero BG, Sacks FM: The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011, 13: 544-552. 10.1007\/s11886-011-0220-3","journal-title":"Curr Cardiol Rep"},{"key":"781_CR20","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2011-1159","volume":"96","author":"A Garg","year":"2011","unstructured":"Garg A: Clinical review: Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011, 96: 3313-3325. 10.1210\/jc.2011-1159","journal-title":"J Clin Endocrinol Metab"},{"key":"781_CR21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.amjmed.2010.03.024","volume":"123","author":"M Rubenfire","year":"2010","unstructured":"Rubenfire M, Brook RD, Rosenson RS: Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events. Am J Med. 2010, 123: 892-898. 10.1016\/j.amjmed.2010.03.024","journal-title":"Am J Med"},{"key":"781_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.metabol.2011.06.002","volume":"61","author":"V Guay","year":"2012","unstructured":"Guay V, Lamarche B, Charest A, Tremblay AJ, Couture P: Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects. Metabolism. 2012, 61: 76-83. 10.1016\/j.metabol.2011.06.002","journal-title":"Metabolism"},{"key":"781_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.nutres.2010.04.007","volume":"30","author":"SH Lee","year":"2010","unstructured":"Lee SH, Chung IM, Cha YS, Park Y: Millet consumption decreased serum concentration of triglyceride and C-reactive protein but not oxidative status in hyperlipidemic rats. Nutr Res. 2010, 30: 290-296. 10.1016\/j.nutres.2010.04.007","journal-title":"Nutr Res"},{"key":"781_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3164\/jcbn.11-38","volume":"50","author":"RY Xu","year":"2012","unstructured":"Xu RY, Wan YP, Fang QY, Lu W, Cai W: Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. J Clin Biochem Nutr. 2012, 50: 72-77.","journal-title":"J Clin Biochem Nutr"},{"key":"781_CR25","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.3748\/wjg.v16.i42.5286","volume":"16","author":"EM Brunt","year":"2010","unstructured":"Brunt EM, Tiniakos DG: Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol. 2010, 16: 5286-5296. 10.3748\/wjg.v16.i42.5286","journal-title":"World J Gastroenterol"},{"key":"781_CR26","first-page":"1045","volume":"54","author":"D Jackuliakov\u00e1","year":"2008","unstructured":"Jackuliakov\u00e1 D, Vaverkov\u00e1 H, Kar\u00e1sek D: Relationship between familial combined hyperlipidemia and insulin resistance. Vnitr Lek. 2008, 54: 1045-1053.","journal-title":"Vnitr Lek"},{"key":"781_CR27","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2165\/11208090-000000000-00000","volume":"71","author":"K McKeage","year":"2011","unstructured":"McKeage K, Keating GM: Fenofibrate: a review of its use in dyslipidaemia. Drugs. 2011, 71: 1917-1946. 10.2165\/11208090-000000000-00000","journal-title":"Drugs"},{"key":"781_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2174\/187153010791213047","volume":"10","author":"AT Kraja","year":"2010","unstructured":"Kraja AT, Province MA, Straka RJ, Ordovas JM, Borecki IB, Arnett DK: Fenofibrate and metabolic syndrome. Endocr Metab Immune Disord Drug Targets. 2010, 10: 138-148.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"781_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.chemphyslip.2011.10.005","volume":"165","author":"ZG Guo","year":"2012","unstructured":"Guo ZG, Li C, Zhong JK, Tu Y, Xie D: Laboratory investigation of dysfunctional HDL. Chem Phys Lipids. 2012, 165: 32-37. 10.1016\/j.chemphyslip.2011.10.005","journal-title":"Chem Phys Lipids"},{"key":"781_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4419-1241-1_10","volume":"662","author":"K Kondo","year":"2010","unstructured":"Kondo K, Sugioka T, Tsukada K, Aizawa M, Takizawa M, Shimizu K, Morimoto M, Suematsu M, Goda N: Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, improves hepatic microcirculatory patency and oxygen availability in a high-fat-diet-induced fatty liver in mice. Adv Exp Med Biol. 2010, 662: 77-82. 10.1007\/978-1-4419-1241-1_10","journal-title":"Adv Exp Med Biol"},{"key":"781_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00204-007-0278-2","volume":"82","author":"J Nishimura","year":"2008","unstructured":"Nishimura J, Dewa Y, Okamura T, Muguruma M, Jin M, Saegusa Y, Umemura T, Mitsumori K: Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats. Arch Toxicol. 2008, 82: 641-654. 10.1007\/s00204-007-0278-2","journal-title":"Arch Toxicol"},{"key":"781_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00204-010-0628-3","volume":"85","author":"MM Tawfeeq","year":"2011","unstructured":"Tawfeeq MM, Suzuki T, Shimamoto K, Hayashi H, Shibutani M, Mitsumori K: Evaluation of in vivo genotoxic potential of fenofibrate in rats subjected to two-week repeated oral administration. Arch Toxicol. 2011, 85: 1003-1011. 10.1007\/s00204-010-0628-3","journal-title":"Arch Toxicol"},{"key":"781_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ejcb.2011.02.005","volume":"90","author":"D Yamasaki","year":"2011","unstructured":"Yamasaki D, Kawabe N, Nakamura H, Tachibana K, Ishimoto K, Tanaka T, Aburatani H, Sakai J, Hamakubo T, Kodama T, Doi T: Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPAR\u03b1-independent mechanisms. Eur J Cell Biol. 2011, 90: 657-664. 10.1016\/j.ejcb.2011.02.005","journal-title":"Eur J Cell Biol"},{"key":"781_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/0192623309336152","volume":"37","author":"T Ohta","year":"2009","unstructured":"Ohta T, Masutomi N, Tsutsui N, Sakairi T, Mitchell M, Milburn MV, Ryals JA, Beebe KD, Guo L: Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol. 2009, 37: 521-535. 10.1177\/0192623309336152","journal-title":"Toxicol Pathol"},{"key":"781_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0891-5849(03)00506-9","volume":"35","author":"HL Jiao","year":"2003","unstructured":"Jiao HL, Ye P, Zhao BL: Protective effects of green tea polyphenols on human HepG2 cells against oxidative damage of fenofibrate. Free Radic Biol Med. 2003, 35: 1121-1128. 10.1016\/S0891-5849(03)00506-9","journal-title":"Free Radic Biol Med"},{"key":"781_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2710.2009.01029.x","volume":"34","author":"D Hajdu","year":"2009","unstructured":"Hajdu D, Aiglov\u00e1 K, Vinklerov\u00e1 I, Urb\u00e1nek K: Acute cholestatic hepatitis induced by fenofibrate. J Clin Pharm Ther. 2009, 34: 599-602. 10.1111\/j.1365-2710.2009.01029.x","journal-title":"J Clin Pharm Ther"},{"key":"781_CR37","volume-title":"Lipids Health Dis","author":"S Redondo","year":"2011","unstructured":"Redondo S, Mart\u00ednez-Gonz\u00e1lez J, Urraca C, Tejerina T: Emerging therapeutic strategies to enhance HDL function. Lipids Health Dis. 2011, 10.1186\/1476-511X-10-175."},{"key":"781_CR38","volume-title":"Lipids Health Dis","author":"T Aoki","year":"2012","unstructured":"Aoki T, Abe T, Yamada E, Matsuto T, Okada M: Increased LDL susceptibility to oxidation accelerates future carotid artery atherosclerosis. Lipids Health Dis. 2012, 10.1186\/1476-511X-11-4."},{"key":"781_CR39","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1517\/14656561003774080","volume":"11","author":"K Toutouzas","year":"2010","unstructured":"Toutouzas K, Drakopoulou M, Skoumas I, Stefanadis C: Advancing therapy for hypercholesterolemia. Expert Opin Pharmacother. 2010, 11: 1659-1672. 10.1517\/14656561003774080","journal-title":"Expert Opin Pharmacother"},{"key":"781_CR40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.phymed.2009.02.004","volume":"16","author":"F Yan","year":"2009","unstructured":"Yan F, Zhang QY, Jiao L, Han T, Zhang H, Qin LP, Khalid R: Synergistic hepatoprotective effect of Schisandrae lignans with Astragalus polysaccharides on chronic liver injury in rats. Phytomedicine. 2009, 16: 805-813. 10.1016\/j.phymed.2009.02.004","journal-title":"Phytomedicine"},{"key":"781_CR41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-2006-958032","volume":"61","author":"KM Ko","year":"1995","unstructured":"Ko KM, Ip SP, Poon MK, Wu SS, Che CT, Ng KH, Kong YC: Effect of a lignan-enriched fructus schisandrae extract on hepatic glutathione status in rats: protection against carbon tetrachloride toxicity. Planta Med. 1995, 61: 134-137. 10.1055\/s-2006-958032","journal-title":"Planta Med"},{"key":"781_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.chroma.2005.01.025","volume":"1066","author":"T Huang","year":"2005","unstructured":"Huang T, Shen P, Shen Y: Preparative separation and purification of deoxyschisandrin and gamma-schisandrin from Schisandra chinensis (Turcz.) Baill by high-speed counter-current chromatography. J Chromatogr A. 2005, 1066: 239-242. 10.1016\/j.chroma.2005.01.025","journal-title":"J Chromatogr A"},{"key":"781_CR43","first-page":"743","volume":"29","author":"WJ Pan","year":"2004","unstructured":"Pan WJ, Xiao XH, Xiao X, Yuan HL, Zhao YL: Studies on extraction process of Fructus Schisandrae chinensis and Fructus Ligustri lucidi in gandening tablet. China J Chin Mater Med. 2004, 29: 743-745. Chinese.","journal-title":"China J Chin Mater Med"},{"key":"781_CR44","first-page":"24","volume":"13","author":"HF Dai","year":"2000","unstructured":"Dai HF, Zhou J, Peng ZG, Tan NH: Studied on the chemical constituents of Schizandra chinesis. Nat Prod Res Dev. 2000, 13: 24-26. Chinese.","journal-title":"Nat Prod Res Dev"},{"key":"781_CR45","volume-title":"J Sep Sci","author":"WD Zhang","year":"2012","unstructured":"Zhang WD, Wang Q, Wang Y, Wang XJ, Pu JX, Gu Y, Wang R: Application of ultrahigh-performance liquid chromatography coupled with mass spectrometry for analysis of lignans and quality control of Fructus Schisandrae chinensis. J Sep Sci. 2012, 10.1002\/jssc.201200393."},{"key":"781_CR46","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1194\/jlr.M700345-JLR200","volume":"48","author":"MA Valasek","year":"2007","unstructured":"Valasek MA, Clarke SL, Repa JJ: Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse. J Lipid Res. 2007, 48: 2725-2735. 10.1194\/jlr.M700345-JLR200","journal-title":"J Lipid Res"},{"key":"781_CR47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/bdd.774","volume":"32","author":"R Ve\u010de\u0159a","year":"2011","unstructured":"Ve\u010de\u0159a R, Zacha\u0159ov\u00e1 A, Orolin J, Strojil J, Skottov\u00e1 N, Anzenbacher P: Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat. Biopharm Drug Dispos. 2011, 32: 482-487. 10.1002\/bdd.774","journal-title":"Biopharm Drug Dispos"},{"key":"781_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.burns.2011.12.004","volume":"38","author":"IE Elijah","year":"2012","unstructured":"Elijah IE, B\u00f8rsheim E, Maybauer DM, Finnerty CC, Herndon DN, Maybauer MO: Role of the PPAR-\u03b1 agonist fenofibrate in severe pediatric burn. Burns. 2012, 38: 481-486. 10.1016\/j.burns.2011.12.004","journal-title":"Burns"},{"key":"781_CR49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.metabol.2006.01.020","volume":"55","author":"AV Ferreira","year":"2006","unstructured":"Ferreira AV, Parreira GG, Green A, Botion LM: Effects of fenofibrate on lipid metabolism in adipose tissue of rats. Metabolism. 2006, 55: 731-735. 10.1016\/j.metabol.2006.01.020","journal-title":"Metabolism"},{"key":"781_CR50","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1742-7843.2011.00748.x","volume":"109","author":"CX Yao","year":"2011","unstructured":"Yao CX, Li WY, Zhang SF, Zhang SF, Zhang HF, Zang MX: Effects of Doxorubicin and Fenofibrate on the activities of NADH oxidase and citrate synthase in mice. Basic Clin Pharmacol Toxicol. 2011, 109: 452-456. 10.1111\/j.1742-7843.2011.00748.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"781_CR51","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.3748\/wjg.v17.i19.2379","volume":"17","author":"JH Chu","year":"2011","unstructured":"Chu JH, Wang H, Ye Y, Chan PK, Pan SY, Fong WF, Yu ZL: Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. World J Gastroenterol. 2011, 17: 2379-2388. 10.3748\/wjg.v17.i19.2379","journal-title":"World J Gastroenterol"},{"key":"781_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.tox.2009.04.058","volume":"261","author":"HY Yu","year":"2009","unstructured":"Yu HY, Wang BL, Zhao J, Yao XM, Gu Y, Li Y: Protective effect of bicyclol on tetracycline-induced fatty liver in mice. Toxicology. 2009, 261: 112-118. 10.1016\/j.tox.2009.04.058","journal-title":"Toxicology"},{"key":"781_CR53","first-page":"23","volume":"43","author":"T Tang","year":"2008","unstructured":"Tang T, Li Y: Protective effect of bicyclol against acute fatty liver induced by tetracycline in mice. Acta Pharm Sin. 2008, 43: 23-28. Chinese.","journal-title":"Acta Pharm Sin"},{"key":"781_CR54","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1745-7254.2006.00332.x","volume":"27","author":"SY Pan","year":"2006","unstructured":"Pan SY, Yang R, Han YF, Dong H, Feng XD, Li N, Geng W, Ko KM: High doses of bifendate elevate serum and hepatic triglyceride levels in rabbits and mice: animal models of acute hypertriglyceridemia. Acta Pharmacol Sin. 2006, 27: 673-678. 10.1111\/j.1745-7254.2006.00332.x","journal-title":"Acta Pharmacol Sin"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-11-120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1476-511X-11-120\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-11-120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:42:41Z","timestamp":1548204161000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-11-120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,19]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-11-120","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,19]]},"article-number":"120"}}